NCT06706076 - A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations | Biotech Hunter

Enrollment

266

Participants

Timeline

Start Date

January 9, 2025

Primary Completion Date

January 31, 2029

Study Completion Date

July 31, 2029

Conditions

NSCLC (Advanced Non-small Cell Lung Cancer)

Interventions

DRUG

BH-30643

BH-30643 will be provided as either 10 mg or 40 mg capsules. Subjects will take BH-30643 orally depending on their dose level assignment.

DRUG

BH-30643

BH-30643 will be provided as either 10 mg or 40 mg capsules. Subjects will take BH-30643 orally depending on their dose level assignment.

Trial Locations (30)

3000

RECRUITING

Peter MacCallum Cancer Centre, Melbourne

3084

RECRUITING

Austin Health, Heidelberg

19107

RECRUITING

Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia

20007

RECRUITING

Georgetown University Medical Center, Washington D.C.

22031

RECRUITING

NEXT Virginia, Fairfax

32224

RECRUITING

Mayo Clinic - Florida, Jacksonville

32746

RECRUITING

Sarah Cancer Research Institution - Florida Cancer Specialist, Lake Mary

33612

RECRUITING

Moffitt Cancer Center, Tampa

37203

RECRUITING

Sarah Cannon Research Institute, LLC, Nashville

48202

RECRUITING

Henry Ford Health, Detroit

55905

RECRUITING

Mayo Clinic Hospital - Rochester, MN, Rochester

60611

RECRUITING

Northwestern Medicine - Northwestern Memorial Hospital Galter Pavilion, Chicago

77030

RECRUITING

The University of Texas - M.D. Anderson Cancer Center, Houston

85054

RECRUITING

Mayo Clinic Hospital - Arizona, Phoenix

92093

RECRUITING

UC San Diego Moores Cancer Center, La Jolla

92697

RECRUITING

The Regents of the University of California - Irvine, CA Campus, Irvine

93586

RECRUITING

Sarawak General Hosital, Kuching

95817

RECRUITING

University of California, Davis Comprehensive Cancer Center, Sacramento

119074

RECRUITING

National University Hospital, Kent Ridge

168583

RECRUITING

National Cancer Centre - Singapore, Singapore

02214

RECRUITING

Massachusetts General Hospital, Boston

02215

RECRUITING

Beth Israel Deaconess Medical Center, Boston

RECRUITING

Dana-Farber Cancer Institute, Boston

T6G1Z2

RECRUITING

Cross Cancer Insitute, Edmonton

Unknown

RECRUITING

Prince of Wales Hospital, Shatin

RECRUITING

Kindai University Hospital, Osakasayama-shi

RECRUITING

National Cancer Center Hospital, Tsukiji

RECRUITING

National Taiwan University Cancer Center, Taipei

RECRUITING

National Taiwan University Hospital, Taipei

227-8577

RECRUITING

National Cancer Center Hospital East, Kashiwa